CLINICAL_TRIALS
research
· 2025-07-11
Clinical Trial Update: Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia [Phase 2]
Summary
Phase 2 clinical trial evaluating the efficacy, safety, and tolerability of 4-MUST tablets in patients with chronic cholecystitis and biliary dyskinesia; the st…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Valenta Pharm JSC | Conditions: Chronic Cholecystitis, Biliary Dyskinesia | Phase 2 | Status: RECRUITING